Overview of Genomic Workflows at The Ohio Department of Health Laboratory

Jade Mowery, MPH

Molecular Supervisor, Ohio Department of Health Public Health Laboratory (ODHL), Reynoldsburg, OH

DESCRIPTION:

Overview of whole genome sequencing, bioinformatics, and how genomic data can be used for outbreak investigations and surveillance in Ohio.

OBJECTIVES:

• Review the basics of whole genome sequencing
• Outline the basics of bioinformatics
• Summarize genomic epidemiology (how genomics can be used in public health for outbreak investigations and surveillance)

LEVEL OF INSTRUCTION:

INTERMEDIATE= Refresher course; some basic knowledge required

CE CONTACT HOURS:  1 hour

Select Agents and Biosafety

Eric St Germain

Preparedness Coordinator/ Laboratory Scientist III, Ohio Department of Health Public Health Laboratory (ODHL), Reynoldsburg, OH

Caitlin McDonnell

Supervisor - LRN BT, Outreach, and Enterics, Ohio Department of Health Public Health Laboratory (ODHL), Reynoldsburg, OH

DESCRIPTION:

Review of select agents, focused on recent history and findings in Ohio. Biosafety discussion will include an overview of the different levels of safety measures, referencing the LRN workflows to show when to start using them, decon. ODHL depts.

OBJECTIVES:

• Distinguish when and how to implement biosafety measures as it pertains to select agents
• Review select agents with emphasis of historical data, sentinel tests required of clinical labs
• Explain the relationship between clinical laboratories and ODHL

LEVEL OF INSTRUCTION:

INTERMEDIATE= Refresher course; some basic knowledge required

CE CONTACT HOURS:  1 hour

Some things never get old

Phyu Thwe, PhD., D(ABMM), MLS(ASCP)CM

Associate Director, Infectious Disease Testing Laboratory, Montefiore Medical Center, Bronx, NY

DESCRIPTION:

In this session, we will discuss AFB culturing, specimen handling, and the importance of incorporating MTB/RIF PCR in the workflow.

OBJECTIVES:

• Review AFB culture set up
• Recognize clinically significant mycobacterial pathogens and culture conditions
• Describe the important role of MTB/RIF PCR in clinical and laboratory settings

LEVEL OF INSTRUCTION:

INTERMEDIATE= Refresher course; some basic knowledge required

CE CONTACT HOURS:  1 hour

MDRO and their Impact

Rebekah Carman, MPH

Antimicrobial Resistance Laboratory Network (ARLN) Subject Matter Expert, Ohio Department of Health Laboratory (ODHL), Reynoldsburg, OH

Natalie Hall, RN

Infectious Disease Control Consultant, Ohio Department of Health Laboratory (ODHL), Reynoldsburg, OH

DESCRIPTION:

In this session, Bekah & Natalie will define MDROs and CROs and identify which MDROs CDC has identified as urgent threats. They will describe the impact of MDROs and how to prevent the spread. They will outline the laboratory testing, results, and interpretations of carbapenem resistance and how these factors can help guide infection control.

OBJECTIVES:

• Define MDRO and CRO and identify those of highest concern
• Summarize laboratory testing of MDRO/CRO and why/how this testing can help mitigate transfer within a facility
• Identify the burden of MDRO/CRO on healthcare and prevention strategies and laboratory testing can help stop the spread and reduce the burden

LEVEL OF INSTRUCTION:

INTERMEDIATE= Refresher course; some basic knowledge required

CE CONTACT HOURS:  1 hour

Macy Wood, PhD, D(ABMM)

SCACM State Director-
Wisconsin

from Wisconsin Diagnostic Laboratories/Froedtert Health
Milwaukee, WI